Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00125034
Status:
COMPLETED
Last Update Posted:
2014-08-07
First Post:
2005-07-28
Brief Title:
Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer mCRC
Sponsor:
Merck KGaA Darmstadt Germany
Organization:
Merck KGaA Darmstadt Germany